XOMAP Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 May 2024 @ 16:00):

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health...

Stats
Today's Volume	11.00
Average Volume	1 141.00
Market Cap	294.46M
EPS	$0 ( 2024-05-20 )
Next earnings date	( $0 ) 2024-08-06
Last Dividend	$0.539 ( 2023-10-04 )
Next Dividend	$0 ( N/A )
P/E	25.27
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-08	Hughes Owen	Buy	275 000	Performance Stock Units
2023-10-03	Sitko Bradley	Buy	250	Common Stock
2023-10-02	Sitko Bradley	Buy	1 500	Common Stock
2023-10-02	Hughes Owen	Buy	1 000	Common Stock
2023-09-26	Hughes Owen	Buy	2 499	Common Stock

INSIDER POWER
100.00
Last 90 transactions
Buy: 3 445 824 \| Sell: 117 506

XOMA Corporation Correlation

10 Most Positive Correlations
EYEG	0.829

10 Most Negative Correlations
ALVR	-0.87

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

XOMA Corporation Financials

Annual	2023
Revenue:	$4.76M
Gross Profit:	$3.86M (81.08 %)
EPS:	$-3.56

FY	2023
Revenue:	$4.76M
Gross Profit:	$3.86M (81.08 %)
EPS:	$-3.56

FY	2022
Revenue:	$6.03M
Gross Profit:	$5.93M (98.39 %)
EPS:	$-1.500

FY	2021
Revenue:	$38.16M
Gross Profit:	$0.00 (0.00 %)
EPS:	$0

Financial Reports:

No articles found.

XOMA Corporation Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.539 (N/A)	$0 (N/A)	$0.539 (N/A)	$1.078 (N/A)	$0 (N/A)	$0.539 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

XOMA Corporation Dividend Information - Dividend Knight

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.719	2021-03-31
Last Dividend	$0.539	2023-10-04
Next Dividend	$0	N/A
Payout Date	2023-10-16
Next Payout Date	N/A
# dividends	11	--
Total Paid Out	$6.11	--
Avg. Dividend % Per Year	5.02%	--
Score	3.62	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-07-15)

$0.550 Estimate 20.00 %

Dividend Stability

0.53 Average

Dividend Score

3.62

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2021	$1.797	7.14%
2022	$2.16	8.31%
2023	$2.16	8.82%
2024	$0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
OXLC	Dividend Diamond	2023-12-14	Monthly	14	10.00%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
OXSQ	Dividend Royal	2023-12-14	Monthly	21	9.10%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
HRZN	Dividend Royal	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-6.82	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.181	1.200	-6.02	-7.22	[0 - 0.3]
returnOnEquityTTM	-0.409	1.500	-5.66	-8.49	[0.1 - 1]
payoutRatioTTM	-0.138	-1.000	-1.381	1.381	[0 - 1]
currentRatioTTM	9.45	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	9.44	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	8.78	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0.550	-1.500	0.830	-1.245	[0 - 0.6]
interestCoverageTTM	-5.93	1.000	-3.31	-3.31	[3 - 30]
operatingCashFlowPerShareTTM	-1.620	2.00	-0.540	-1.080	[0 - 30]
freeCashFlowPerShareTTM	-2.89	2.00	-1.444	-2.89	[0 - 20]
debtEquityRatioTTM	1.466	-1.500	4.14	-6.20	[0 - 2.5]
grossProfitMarginTTM	0.884	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	-4.20	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.155	1.000	-1.974	-1.974	[0.2 - 2]
assetTurnoverTTM	0.0265	0.800	-3.16	-2.53	[0.5 - 2]
Total Score				-0.942

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-7.54	1.000	-0.863	0	[1 - 100]
returnOnEquityTTM	-0.409	2.50	-3.64	-8.49	[0.1 - 1.5]
freeCashFlowPerShareTTM	-2.89	2.00	-0.963	-2.89	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-1.620	2.00	-0.540	-1.080	[0 - 30]
payoutRatioTTM	-0.138	1.500	-1.381	1.381	[0 - 1]
pegRatioTTM	-0.148	1.500	-4.32	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-3.23	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-3.15

XOMA Corporation Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

XOMA Corporation

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.